The objective of this call for tenders is to strengthen the scientific evidence on the immunity provided by the Modified Vaccinia Ankara virus-Bavarian Nordic (MVA-BN) vaccine, with particular emphasis on the need and optimal timing of booster doses.
Funded under the EU Third health programme, the RISE-Vac project aims to improve the health of prison population in Europe by promoting vaccine literacy and improving the offer and uptake of vaccines.
Join the one-day conference in Brussels to hear more about the results of the study and meet other national health authorities.
On behalf of the Health Emergency Preparedness and Response Authority (HERA), HaDEA has signed a framework contract with four contractors setting up the EU FAB network. Their manufacturing capacities will be kept operational and can be activated quickly, securing a total of 325 million doses per year in case of a public health emergency.
